Showing results (121-130 of 283) with videos related to
Sort By:
Pageof 29
Investigational New Drugs|January 1, 1984
A method for the simultaneous measurement of the new anthracycline derivative 4'-deoxydoxorubicin and its metabolites by reversed phase liquid chromatographyY M Peng, D S Alberts, S E Salmon, et al.European Journal of Cancer & Clinical Oncology|November 1, 1983
Tumor growth stimulation in vitro by interferonsC U Ludwig, B G Durie, S E Salmon, et al.Seminars in Oncology|October 1, 1991
alpha-Interferon for remission maintenance: preliminary report on the Southwest Oncology Group StudyS E Salmon, J Beckord, R P Pugh, et al.International Journal of Cancer|December 15, 1982
Effect of epidermal growth factor on clonogenic growth of primary human tumor cellsM A Pathak, L M Matrisian, B E Magun, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1985
The human tumor clonogenic assay in human breast cancerS E Jones, J C Dean, L A Young, et al.Cancer|January 1, 1978
Predictive value of bone scans in an adjuvant breast cancer programN Hammond, S E Jones, S E Salmon, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Cytotoxicity of mitomycin C on clonogenic human carcinoma cells is not enhanced by hypoxiaC U Ludwig, Y M Peng, J N Beaudry, et al.Journal of Immunological Methods|March 27, 1990
Modification of the clonogenic assay for the detection of lymphokine activated killer cell activityP Scuderi, L Woo, A S Chong, et al.Blood|October 1, 1989
Effects of tumor necrosis factor on sensitive and multidrug resistant human leukemia and myeloma cell linesS E Salmon, B Soehnlen, W S Dalton, et al.Cancer Letters|November 1, 1975
Combination chemotherapy with methyl-CCNU (NSC-95441), cyclophosphamide (NSC-26271), vincristine (NSC-67574), methotrexate (NSC-740), and bleomycin (NSC-125066) in advanced bronchogenic carcinomaL J McMahon, S E Jones, B G Durie, et al.Pageof 29